The measurement of the impact of breathlessness in advanced COPD

P. White, C. Shipman, S. Booth, C. Bausewein, M. Farquhar, I. Higginson, H. Booth (London, Cambridge, United Kingdom)

Source: Annual Congress 2011 - Quality of life and respiratory symptom management in primary care
Session: Quality of life and respiratory symptom management in primary care
Session type: Thematic Poster Session
Number: 685
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. White, C. Shipman, S. Booth, C. Bausewein, M. Farquhar, I. Higginson, H. Booth (London, Cambridge, United Kingdom). The measurement of the impact of breathlessness in advanced COPD. Eur Respir J 2011; 38: Suppl. 55, 685

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The impact of frequent exacerbations on air-trapping, dyspnea, exercise capacity and quality of life in stable COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 176s
Year: 2006

An exploration of dyspnoea and determinants in patients with COPD
Source: Virtual Congress 2020 – Novel insights into nursing interventions for managing patients with asthma and COPD
Year: 2020




Impact of nighttime and early morning symptoms on HRQoL and work productivity of COPD patients
Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings
Year: 2013


The impact of dyspnoea and strategies used by lung fibrosis patients to relieve breathlessness.
Source: International Congress 2017 – The wide spectrum of ILDs
Year: 2017


Relationship between severity of bronchial and systemic inflammation, and dyspnea, exercise performance and quality of life in patients with stable COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 37s
Year: 2006

Detection of quality of life with COPD assessment test in chronic obstructive pulmonary disease and effect of dyspnea on disease-specific quality of life in these patients
Source: Annual Congress 2012 - Methodology in epidemiologic research
Year: 2012

The evaluation of dyspnoea and quality of life in COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 93s
Year: 2001

Determinants of dyspnea in stable COPD patients
Source: Annual Congress 2011 - COPD management
Year: 2011

The relationship of dyspnea and lung function at COPD
Source: Annual Congress 2007 - Pathophysiology and assessment of COPD
Year: 2007


Assessing COPD profiles and outcomes by dyspnoea severity
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016


Effect of dynamic hyperinflation on exertional dyspnea, exercise performance and quality of life in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 171s
Year: 2006

An evaluation of the validity of two measurements of dyspnoea as outcomes of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 182s
Year: 2002

Impact of pulmonary rehabilitation on cough and sputum symptom perception in patients with COPD
Source: International Congress 2015 – Latest insights into pulmonary rehabilitation
Year: 2015


Interpreting thresholds for a clinically significant change in health status in asthma and COPD
Source: Eur Respir J 2002; 19: 398-404
Year: 2002



Physicians’ attitudes to dyspnoea management in advanced chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Latest insights into the management of chronic respiratory diseases
Year: 2016

Does airflow limitation severity in stable condition severity of COPD influences in patient cardiac autonomic modulation in COPD patients during hospitalization for exacerbation?
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020


The evaluation of factors affecting dyspnea and quality of life in COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 123s
Year: 2004

Overdiagnosis of COPD and asthma among elderly with chronic dyspnea
Source: Virtual Congress 2021 – Primary care diagnosis and multimorbidities
Year: 2021


Heliox moderates multidimensional domains of exertional dyspnoea in people with COPD
Source: International Congress 2016 – From cardiopulmonary interaction to locomotor muscles and dyspnoea in health and disease
Year: 2016